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In  many tumor  systems, the  location  and  extent  of metastases  are  nonrandom, 
suggesting that unique cell properties are important in tumor arrest and formation of 
secondary  tumor colonies.  The  lung  and  the  liver are  among the  most  frequently 
involved organs. These organs are also the predominant site of metastases by tumor 
cells of a  model system of chemically induced  lymphomas in  DBA/2  mice that we 
have been investigating (1-5). The system consists of a low-metastatic parental tumor 
(Eb),  a  spontaneous  high-metastatic  variant  thereof (ESb),  and  a  high-metastatic 
tumor line of independent  origin (MDAY-D2). 
We previously described that ESb and MDAY-D2, but not Eb, tumor cells had the 
unique  properties of adhesion  to and  invasion of normal lung tissue in  vitro  (1,  6). 
Now  we  describe  another  unique  characteristic  of the  two  metastatic  tumor  lines, 
namely, a selective binding to isolated hepatocytes in vitro. 
Recently Kolb et al.  (7)  demonstrated a  lectin-like receptor on rat  liver cells that 
has  specificity  for  galactosyl  residues  and  may  play  a  role  in  the  trapping  of 
recirculating desialylated lymphocytes in the liver (8).  In our study, we investigated 
whether  a  similar  interaction  might  be  responsible  for the  trapping  of circulating 
metastatic tumor cells in the liver. 
Materials and Methods 
Tumor Cells.  Eb  is a  Heidelberg subline of the methylcholanthrene-induced DBA/2  lym- 
phoma L5178Y, and ESb is a  spontaneous variant thereof with highly metastatic potential (1, 
5). The etiology of the metastatic DBA/2 tumor MDAY-D2 has been described (9). The tumor 
cells were passaged  in tissue culture using RPMI-1640 medium  (Grand Island Biological Co., 
Grand Island, N. Y.) with  10% fetal calf serum (FCS) and 2  ×  10  -~ M  2-mercaptoethanol, 
Murine Hepatocytes.  Liver cell suspensions were prepared as previously described (10). An 8- 
12-wk-old mouse was injected with 0.3 ml of 3.6% chloral hydrate in phosphated-buffered saline 
and  0.1  ml  of heparin  (500  U/ml).  The  hepatic  portal  vein  and  inferior  vena  cava  were 
cannulated with a  21-gauge needle and a  16-gauge plastic catheter, respectively. The liver was 
perfused in situ, first with perfusion buffer (10) that was saturated with 02 at 36°C for 2-3 min, 
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and then with 0.05%  collagenase in the same buffer for 8-9 min. The liver was then removed, 
cut into pieces, filtered, and then suspended in Williams medium E supplemented with insulin 
and  15% FCS. Cells were washed three times for 15 min at 30g. 2 ×  10  cells were plated into 
wells of Falcon multiwell tissue culture plates (No.  3008;  Falcon Labware, Div.  of Becton, 
Dickinson & Co., Oxnard, Calif.) in a  total vol of 400/~1 supplemented Williams medium E. 
The cells were incubated at 37°C in 5% CO2 for 2-3 h and washed once before use. 
Neuraminidase Treatment of Tumor Cells and Rosette Assay.  Tumor cells were washed three times 
with Hanks' balanced salt solution. 20/xl of Neuraminidase test  (1  U/ml from  Vibrio comma 
[Vibrio cholerae] Behringwerke AG, Marburg/Lahn, Federal Republic of Germany), was added 
to 2 ×  107 tumor cells in 1 ml and incubated at 37°C for 30 min. After three washes, the tumor 
cells were resuspended in 2 ml of Williams medium E. For the rosette assay, 250/~1 of ascites 
tumor-cell suspension (1 ×  107/ml) was added to the hepatocyte culture and incubated at 37°C 
in 5% CO~ for  1 h.  The cultured hepatoeytes were carefully washed three times before the 
number of rosette-forming cells was determined. Hepatocytes with three or more tumor cells 
bound were counted as rosette-forming cells (RFC). 
Antibody-inhibition  Test.  Various alloantisera known to react with the tumor cells were used 
to test for possible blocking of rosette formation. 250/xl of tumor cells (107/ml) were preincubated 
with 25/~1 of appropriately diluted antisera at 37°C for 30 min. After two washes, they were 
then tested for their binding to the hepatocytes. 
Results and  Discussion 
Freshly isolated hepatocytes  from  DBA/2  mice  were  incubated  for  3  h  in  tissue 
culture  medium  in  Petri  dishes  in  order  to  attach  to  the  dishes.  They  were  then 
incubated for 1 h  at 37°C with either of the three syngeneic tumor-cell lines, Eb, ESb, 
and  MDAY-D2,  and carefully washed.  Examination of the cultures by an  inverted 
microscope (Diavert; E. Leitz, Stuttgart, Federal Republic of Germany) revealed that 
the two  metastatic tumor lines ESb and  MDAY-D2  had  attached  to  the liver cells 
whereas the low-metastatic parental tumor Eb had not  (Fig.  1 A  and B). About 40% 
of the hepatoeytes formed spontaneous rosettes with the metastatic tumor line ESb. 
The percentage of RFC and the average number of tumor cells bound per liver cell 
was greatly increased when the tumor cells were pretreated with neuraminidase (Fig. 
1 C  and D). Under these conditions, even the low-metastatic tumor Eb was bound by 
the  hepatocytes  (Fig.  1 C).  Freshly isolated liver cells without  precuhure  showed  a 
decreased  tendency to bind  the tumor cells, so that  no  rosettes were observed with 
untreated tumor cells, and a  smaller percentage bound neurarninidase-pretreated Eb 
or ESb  tumor cells. This observation could be explained by adaptation of the liver 
cells to the tissue culture conditions, attachment to the plastic, and recovery from the 
collagenase pretreatment.  That  the tumor-cell binding was stable or even  increased 
after recovery from enzyme treatment  and was similarly observed after a  prolonged 
culture period (24-72 h) indicates that the receptor responsible for the binding is not 
an  artifact induced  by the collagenase treatment  but  may be real  and  may play a 
physiological role in vivo. 
The results from our syngeneic tumor model system suggest that hepatocytes bind 
metastasizing tumor cells better than  nonmetastasizing ones. It remains to be inves- 
tigated, however, with different tumor lines, whether this is a  general phenomenon. 
Selectivity of the tumor-cell binding to hepatocytes was shown by the fact that other 
normal  cells,  such  as  Kupffer  cells,  peritoneal  macrophages,  lymphoid  cells,  and 
kidney cells (cell line BHK-21)  did not form rosettes. 
The  dependency  of  tumor-hepatocyte-rosette  formation  on  the  temperature  of 
incubation is illustrated in Fig. 2. Virtually no rosettes were formed at 0°C and only 986  SCHIRRMACHER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
FIO.  1.  (A) and  (B) spontaneous rosette formation between cultivated hepatocytes from DBA/2 
mice and the metastatic DBA/2 tumor variant ESb (B), No rosettes were observed with the parental 
line Eb (A). ((3) and (I3) Rosette formation of the same hepatocytes with neuraminidase-pretreated 
parental (Eb-N) or variant (ESb-N) tumor cell lines. The hepatocytes were isolated by a collagenase- 
perfusion technique and precultivate  d for 3 h in vitro. The adherent liver cells were then coincubated 
for  1 h  at  37°C with the tumor cells from suspension  tissue  culture and  then carefully washed. 
Arrows indicate typical rosettes. 
a  few at  4°C, although  at  22°C  about  as many  rosettes  were formed with the tumor 
cells--whether  untreated  or  neuraminidase  pretreated--as  at  37°C.  These  results 
suggest  that  membrane  fluidity  and  possibly  free  movement  of receptors  may  be 
required  for the binding  of metastatic  tumor  cells by  the  hepatocytes.  Pretreatment 
of the liver cells with cytochalasin  B  (5 #g/ml)  for 30  min  at  37°C  did  not  interfere 
with the cells' ability to form  rosettes,  which  indicates  that  intact  microtubules  may 
not be required for binding. 
To characterize  the tumor  cell molecules that  are possibly  involved in the binding 
to  the hepatocytes,  antibody  inhibition  experiments  were performed.  Three  types  of SCHIRRMACHER ET AL.  BRIEF  DEFINITIVE REPORT 
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Fro.  2.  Temperature  dependence of the rosette formation between hepatocytes  and untreated (A) 
or neuraminidase-pretreated (B) tumor-cell lines. Hepatocytes were prepared and precultivated as 
in Fig. 1. They were then adjusted to the indicated temperature and coincubated with the tumor 
cells at this temperature for 1 h. 
antibody were used: alloantibodies directed  (a)  against  H-2,  (b)  against non-H-2, or 
(c)  against  Thy-1  antigens  from  DBA/2  mice.  Normal  or  neuraminidase-treated 
DBA/2 tumor cells were pretreated with various amounts of these respective antisera, 
washed, and then tested for binding to the hepatocytes. Some representative results of 
such blocking experiments are given in Table I. With the metastatic tumor line ESb, 
anti-H-2 sera produced quite strong inhibition, whereas the other two alloantibodies 
had either no effect  (anti-non-H-2)  or a  comparatively weak inhibitory effect  (anti- 
Thy-l.2). In contrast, when using the parental line Eb, which only bound to the liver 
cells  after neuraminidase  treatment,  all  three sera  produced quite a  good blocking 
effect. Compared to the cytotoxic titer assayed against the untreated tumor cells, anti- 
non-H-2 serum was the strongest inhibitor of rosettes formed with Eb-N, whereas the 
anti-H-2 serum was the strongest inhibitor of rosettes formed with ESb or ESb-N. 
Little is known about the mechanism of the tumor-cell-hepatocyte binding and its 
inhibition  by  specific  antibody.  Preliminary  results  indicate  that  the  previously 
described lectin-like hepatic membrane receptor (7,  11) may mediate the spontaneous 
binding of the tumor cells.  Exposure of hepatocytes to neuraminidase abolished their 
ability to specifically bind  desialylated  glycoproteins (12),  and  also abolished  their 
ability to bind the metastatic and the neuraminidase-treated Eb and ESb tumor cells 
(V.  Schirrmacher,  R.  Cheingsong-Popov, and  H.  Arnheiter.  Unpublished  results.). 
The  blocking  by  anti-H-2  serum  was  only  observed  when  the  tumor  cells  were 
pretreated,  and  not  when  the  hepatocytes  were  pretreated  with  the  antiserum. 
Allogeneic hepatocytes from C57BL/6 (H-2  b)  formed rosettes equally well with ESb 
(H-2  d)  as  did  the  syngeneic hepatocytes  from  DBA/2  (H-2d),  which  suggests  that 
alloantigenic compatibility is not required for the rosette formation. However, anti- 
H-2  d serum inhibited ESb rosettes with allogeneic as well as with syngeneic hepato- 
cytes  (V.  Schirrmacher,  R.  Cheingsong-Popov,  and  H.  Arnheiter.  Unpublished 
Results.). These results may indicate that H-2 molecules play a role in the spontaneous 
interaction  of the metastatic tumor cells  with  the hepatocytes. Binding of anti-H-2 
antibody to  the  H-2  molecules possibly  blocks by steric  hindrance  rather  than  by 
covering up the determinants recognized by the hepatocyte receptor, because alloan- 
tigenic determinants do not seem to be involved. 
A  number of other cell-interaction  phenomena have been  described  to be under 988  SCHIRRMACHER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Effect of Preincubation of Tumor Cells with DO'ned Alloantisera  on Their Ability to Form Rosettes with 
Isolated Syngeneic Hepatocytes 
Experi-  Preincubation  Dilu- 
ment 
with  tion 
number 
Tumor cell-hepatocyte-rosette formation 
ESb  ESb-N  Eb  Eb-N 
Inhibi-  Inhibi-  Inhibi- 
RFC  RFC  RFC  RFC 
tion  tion  tion 
% 
--  80  86  <  1  92 
Anti-H-2  a*  1 : 16  13  84  6  93  --  6  93 
Anti-H-2  a  1:64  27  66  26  70  --  47  50 
Anti-H-2  a  1:256  50  38  60  30  --  88  7 
Anti-H-2  d  1 : 1,024  80  0  84  2  --  87  5 
II  --  92  94  <  1  84 
Anti-non-H-2$  1:4  88  4  92  2  --  13  85 
Anti-non-H-2  1  : 16  89  3  92  2  --  24  71 
Anti-non-H-2  1:64  90  2  94  0  --  47  44 
Anti-non-H-2  1:256  92  0  94  0  --  84  0 
Anti-Thy- 1.2§  1:4  44  52  73  22  --  47  44 
Anti-Thy-l.2  1:16  69  25  89  5  --  50  40 
Anti-Thy- 1.2  1:64  92  0  90  4  --  77  8 
Anti-Thy- 1.2  1:256  93  0  91  3  --  92  0 
* This CBA/J  anti-BALB/c alloantiserum (No. 456)  had a  50% cytotoxicity titer of 1:500 against Eb and 
one of 1  : 175 against ESb. 
~t This B10.D2 anti-DBA/2 alloantiserum obtained after skin graft rejection had a  50% cytotoxicity titer of 
1:20 against Eb and one of 1:4 against ESb. The cytotoxicity titer against Eb-N could not be determined 
because the majority of cells were lysed by complement in the absence of antibody. 
§ The  cytotoxicity titer of this  monoclonal  antibody  (OLAC  Ltd.,  Shaw's  Farm,  Blackthorn,  Bicester, 
Oxon, England) was 1:250 against Eb and  l:10 against ESb. 
H-2 control: they include lymphocyte-lymphocyte and lymphocyte-macrophage in- 
teractions (13)  and also nonimmunological reactions such as the adhesion of mouse 
fibroblasts (14) or the contact inhibition of kidney epithelial cells  (15). 
Further studies are aimed at a better characterization of the molecules involved in 
the interaction of normal hepatocytes with neoplastic cells. This may help to elucidate, 
at a molecular level,  the liver tropism of many metastatic tumor cells and possibly to 
find selective competitive inhibitors for this process. 
Summary 
Murine  hepatocytes,  isolated  by  an  in  situ  collagenase-perfusion  technique  and 
cultured in Petri dishes, were shown to form rosettes with liver-metastasizing syngeneic 
tumor cells.  Pretreatment of the tumor cells with neuraminidase generally increased 
the binding, whereas pretreatment of the liver cells with neuraminidase abolished the 
binding  completely.  The  tumor-cell  binding  may  be  mediated  by  the  previously 
described lectin-like receptor of hepatocytes that also was sensitive to neuraminidase 
treatment and that bound desialylated cells  better than normal cells. 
Anti-H-2 sera could efficiently inhibit  the  rosette  formation of metastatic  tumor 
cells  with  the  hepatocytes, which points  to a  possible role of H-2 molecules in  this 
interaction of neoplastic and normal cells. SCHIRRMACHER  ET AL.  BRIEF  DEFINITIVE  REPORT  989 
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